SEC Form 4 · accession 0001782135-26-000024
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Johanna Mercier
Officer — Chief Comm & Corp Aff Officer
Period of report
Jun 15, 2026
Accepted (ET)
Jun 16, 2026 · 6:02 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 15, 2026 | S | 1,480 | $123.4166 | D | 125,754 | D | |
| Common StockF3 | Jun 15, 2026 | S | 1,070 | $123.9958 | D | 124,684 | D | |
| Common Stock | Jun 15, 2026 | S | 450 | $125.40 | D | 124,234 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
- F2Sale prices for the transactions reported range from $122.79 to $123.785. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F3Sale prices for the transactions reported range from $123.81 to $124.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.